This inventor holds 1 USPTO granted patent. Top assignee: Neuraxon, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Gabriela Mladenova: Innovator in Pain Management
Introduction
Gabriela Mladenova is a notable inventor based in Thornhill, CA. She has made significant contributions to the field of pain management through her innovative research and development of therapeutic methods.
Latest Patents
Mladenova holds a patent for "Indole compounds and methods for treating visceral pain." This invention features methods for treating visceral pain or conditions in mammals caused by the action of nitric oxide synthase (NOS) or serotonin 5HT1D/1B receptors. The patent outlines the administration of a therapeutically effective amount of an indole compound of Formula (I), or a pharmaceutically acceptable salt or prodrug thereof. Additionally, the methods may include the administration of other therapeutic agents, and the invention introduces new compounds of Formula (I), pharmaceutical compositions, and methods for resolving enantiomeric mixtures. She has 1 patent to her name.
Career Highlights
Mladenova is associated with Neuraxon, Inc., where she continues to advance her research in the pharmaceutical field. Her work focuses on developing effective treatments for visceral pain, showcasing her commitment to improving patient care.
Collaborations
Mladenova collaborates with talented professionals in her field, including Shawn Maddaford and Jailall Ramnauth. These partnerships enhance her research and contribute to the development of innovative solutions in pain management.
Conclusion
Gabriela Mladenova is a pioneering inventor whose work in developing methods for treating visceral pain has the potential to significantly impact the medical field. Her dedication to innovation and collaboration underscores her role as a leader in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile